Cargando…
Hydrocortisone increases the risk of dysglycemia in critically ill patients
Autores principales: | Van Hooijdonk, RT, Binnekade, JM, Harmsen, RE, Schultz, MJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363575/ http://dx.doi.org/10.1186/cc10764 |
Ejemplares similares
-
Point accuracy and reliability of an interstitial continuous glucose monitoring device in critically ill patients
por: Hooijdonk, R Van, et al.
Publicado: (2015) -
Continuous prediction of glucose-level changes using an electronic nose in critically ill patients
por: Leopold, JH, et al.
Publicado: (2014) -
Point and trend accuracy of continuous glucose monitoring using intravenous microdialysis in critically ill patients
por: Leopold, JH, et al.
Publicado: (2015) -
Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control
por: van Hooijdonk, Roosmarijn T. M., et al.
Publicado: (2015) -
Mild hypoglycemia is independently associated with increased mortality in the critically ill
por: Krinsley, J, et al.
Publicado: (2011)